Metformin Actavis

Metformin, the active ingredient in Metformin Actavis, is a Biguanide presented as an oral tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adult patients, helping to control elevated blood glucose levels by decreasing hepatic glucose production and improving peripheral insulin sensitivity.

GNH USA supplies Metformin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, quality assurance and regulatory support for global distribution to meet diverse market needs.

Metformin Actavis, a Biguanide antidiabetic agent, is used to improve glycemic control in several glucose‑related conditions.

Type 2 diabetes mellitus: improves blood glucose control and reduces HbA1c levels. Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when combined with lifestyle measures. Polycystic ovary syndrome: reduces insulin resistance and may improve menstrual regularity.

Metformin may cause a range of adverse reactions, most of which are related to the gastrointestinal tract, while rare events can be serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite - Diarrhea: frequent loose stools - Metallic taste: transient alteration in taste perception

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal accumulation of lactate - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic failure: marked liver dysfunction in predisposed patients

Metformin should be used with careful clinical monitoring and patient education. - Renal function: assess creatinine clearance before initiating and periodically thereafter - Liver disease: use with caution in patients with hepatic impairment - Alcohol consumption: avoid excessive intake to reduce lactic acidosis risk - Risk of hypoglycemia: monitor when combined with insulin or sulfonylureas - Pregnancy and lactation: discuss benefits and risks with healthcare provider - Store at room temperature: keep in original container, protect from moisture and heat

Metformin can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Iodinated contrast agents (intravenous): may precipitate lactic acidosis; discontinue metformin before and after use - Cimetidine: can increase metformin plasma concentrations

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms - Diuretics (especially thiazides): can affect renal clearance of metformin - ACE inhibitors or ARBs: monitor renal function and potassium levels